Treating leukemia with cord-blood transplant looks promising

September 8, 2016

(HealthDay)—Umbilical cord blood may work as well as current alternatives for adults and children with leukemia—or even better in some cases, according to a study published in the Sept. 8 issue of the New England Journal of Medicine.

To compare the success of the different options, researchers looked at 582 patients with leukemia or myelodysplastic syndrome. If a compatible or stem cell transplant from an unrelated donor wasn't available, the patients received either a cord-blood transplant or an incompatible bone marrow or stem cell transplant from an unrelated donor.

"Our study showed that overall survival after cord-blood transplantation was comparable to the one observed after matched unrelated transplants," lead author Filippo Milano, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, told HealthDay. And patients who got cord-blood transplants seemed to live longer than those who got non-matching bone marrow or from unrelated donors, he noted. The cord blood approach appeared especially beneficial for a subset of patients with minimal residual disease.

"Often, cord-blood transplant is thought to be only as the last resource for without donors. But cord blood does not have to be considered only an alternative donor source," Milano said. "In centers with experience, it can yield to great outcomes."

Explore further: Cord blood outperforms matched, unrelated donor in bone marrow transplant

More information: Abstract
Full Text

Related Stories

Cord blood outperforms matched, unrelated donor in bone marrow transplant

July 26, 2016
A University of Colorado Cancer Center study compared outcomes of leukemia patients receiving bone marrow transplants from 2009-2014, finding that three years post transplant, the incidence of severe chronic graft-versus-host ...

Bone marrow-derived stem cells offer blood transplant patients better quality of life

August 16, 2016
A large, nationwide study published in the journal JAMA Oncology found that people who received transplants of cells collected from a donor's bone marrow the original source for blood stem cell transplants, developed decades ...

No survival advantage with peripheral blood stem cells versus bone marrow

October 19, 2012
(Medical Xpress)—Claudio Anasetti, M.D., chair of the Department of Blood & Marrow Transplant at Moffitt Cancer Center, and colleagues from 47 research sites in the Blood and Marrow Transplant Clinical Trials Network conducted ...

Source of stem cells used for bone marrow failure treatment varies worldwide

January 12, 2016
Ayami Yoshimi, M.D., Ph.D., of the University of Freiburg, Germany, and colleagues examined the use of peripheral blood stem cells and bone marrow as stem cell sources for hematopoietic stem cell transplantation in patients ...

Good odds for those who need bone marrow donor, study finds

July 24, 2014
(HealthDay)—Most blood cancer patients in the United States who need a bone marrow transplant can find an acceptable match through the National Marrow Donor Program, a new study has determined.

Recommended for you

Researchers identify blood biomarkers that may help diagnose, confirm concussions

April 20, 2018
Researchers from the University of California, Irvine, Georgetown University and the University of Rochester have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained ...

DOR protein deficiency favors the development of obesity

April 20, 2018
Obesity is a world health problem. Excessive accumulation of fat tissue (adipose tissue) increases the risk of cardiovascular disease, hypertension, diabetes and some types of cancer. However, some obese individuals are less ...

Stem-cell technology aids 3-D printed cartilage repair

April 20, 2018
Novel stem-cell technology developed at Swinburne will be used to grow the massive number of stem cells required for a new hand-held 3-D printer that will enable surgeons to create patient-specific bone and cartilage.

Enduring cold temperatures alters fat cell epigenetics

April 19, 2018
A new study in fat cells has revealed a molecular mechanism that controls how lifestyle choices and the external environment affect gene expression. This mechanism includes potential targets for next-generation drug discovery ...

Defect in debilitating neurodegenerative disease reversed in mouse nerves

April 19, 2018
Scientists have developed a new drug compound that shows promise as a future treatment for Charcot-Marie-Tooth disease, an inherited, often painful neurodegenerative condition that affects nerves in the hands, arms, feet ...

Molecule that dilates blood vessels hints at new way to treat heart disease

April 19, 2018
Americans die of heart or cardiovascular disease at an alarming rate. In fact, heart attacks, strokes and related diseases will kill an estimated 610,000 Americans this year alone. Some medications help, but to better tackle ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.